article

TMPRSS2 inhibitors, Bromhexine, Aprotinin, Camostat and Nafamostat as potential treatments for COVID-19

Arsalan Azimi explains why inhibiting TMPRSS2 with clinically proven protease blockers could work as a therapeutic strategy against COVID-19.

Read the research – click here. 

2 responses to “TMPRSS2 inhibitors, Bromhexine, Aprotinin, Camostat and Nafamostat as potential treatments for COVID-19”

  1. Brian Cady says:

    Thank you, Arsalan Azimi,

  2. LUIS ENRIQUE MACIAS BUSTES says:

    DOES TMPRSS2 INHIBIT, COMPLETELY DISCONTINUES SARS-CoV-2VIRUS INTAKE INTO THE CELL?

    WHAT HAPPENS WITH THE INCOME BY THE ENDOSOMAL VIA?

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Send this to a friend